Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Journal of Clinical Microbiology|October 9, 2004
Disseminated infection with Prototheca zopfii after unrelated stem cell transplantation for leukemiaCornelia Lass-Flörl, Manfred Fille, Eberhard Gunsilius, et al.
Case Reports in Oncology|November 1, 2021
Sustained Complete Remission in Multi-Relapsed Primary CNS Lymphoma Treated with Ibrutinib Monotherapy: A Case ReportAnna Mair, Armin Muigg, Günther Stockhammer, et al.
Blood Advances|August 31, 2021
Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic eventsStefan Schmidt, Dimitri Daniliants, Elisabeth Hiller, et al.
Oncotarget|December 16, 2016
Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?Normann Steiner, Angelika Schwärzler, Georg Göbel, et al.
Oncotarget|February 9, 2018
Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patientsNormann Steiner, Georg Göbel, Patricia Suchecki, et al.
Frontiers in Oncology|February 11, 2020
Spliced XBP1 Levels Determine Sensitivity of Multiple Myeloma Cells to Proteasome Inhibitor Bortezomib Independent of the Unfolded Protein Response Mediator GRP78Bojana Borjan, Johann Kern, Normann Steiner, et al.
Oncology|January 10, 2014
New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance moleculesAndreas Pircher, Jasmin Wellbrock, Walter Fiedler, et al.
Immunobiology|April 5, 2003
Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cellsJohannes Clausen, Birgit Vergeiner, Martina Enk, et al.
Haematologica|September 8, 2006
The effect of zoledronic acid on the function and differentiation of myeloid cellsAnna Maria Wolf, Holger Rumpold, Herbert Tilg, et al.
Experimental Hematology|June 21, 2005
RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell linesHolger Rumpold, Anna M Wolf, Kurt Gruenewald, et al.
Pageof 9